Durability of benefits of an outpatient antimicrobial stewardship intervention after discontinuation of audit and feedback

JAMA - Journal of the American Medical Association

Volumn 312, Issue 23, 2014, Pages 2569-2570

  Gerber, Jeffrey S ^a   Prasad, Priya A ^a   Fiks, Alexander G ^a   Localio, A Russell ^b   Bell, Louis M ^a   Keren, Ron ^a   Zaoutis, Theoklis E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

COMORBIDITY; DRUG INFORMATION; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INAPPROPRIATE PRESCRIBING; LETTER; MEDICAL AUDIT; OUTPATIENT CARE; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; SINUSITIS; STANDARDIZATION; STREPTOCOCCAL PHARYNGITIS; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; FEEDBACK SYSTEM; INFECTION; INTERVENTION STUDY; MEDICAL EDUCATION; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFECTIVE AGENTS; CHILD; CLINICAL AUDIT; EDUCATION, MEDICAL, CONTINUING; FEEDBACK; GUIDELINE ADHERENCE; HUMANS; INFECTION; INTERVENTION STUDIES; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84919360129     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14042     Document Type: Letter

References (4)

1. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739-750.
2. Cancer screening. Treat Guidel Med Lett. 2012;10 (124):87-94.
3. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.
4. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171.